Elevated customary alcohol consumption attenuates opioid effects

Regular alcohol consumption is on the rise among older adults and has the potential of altering the subjective experience of pain and response to pain medications. This study examined the cognitive, analgesic and side effect response to oxycodone in middle age and older adults with elevated levels o...

Full description

Saved in:
Bibliographic Details
Published inPharmacology, biochemistry and behavior Vol. 211; p. 173295
Main Authors Cherrier, Monique M., Shen, Danny D., Shireman, Laura, Saxon, Andrew J., Simpson, Tracy, Men, Alex, Kooner, Preetma, Terman, Gregory W.
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.12.2021
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Regular alcohol consumption is on the rise among older adults and has the potential of altering the subjective experience of pain and response to pain medications. This study examined the cognitive, analgesic and side effect response to oxycodone in middle age and older adults with elevated levels of customary alcohol consumption in a human laboratory setting. After refraining from alcohol for one day, eligible participants underwent baseline assessment cognition and side effects by means of questionnaires that were repeated at three time points (90 min, 5 and 8 h) following administration of a 10 mg oral dose of oxycodone. Response to pain stimulus (Cold Pressor Test (CPT)), pupil size, and plasma oxycodone were also measured. One hundred twenty-eight adults (age 35–85) completed the study day. Compared to those with lower customary alcohol consumption, participants with elevated alcohol consumption showed attenuated opioid-induced pupil constriction and cognitive decline on objective measures of working memory, sustained attention, inhibitory control, coordination on a simulated driving task, and subjective dysphoric effects with enhanced subjective euphoric effects. Oxycodone pharmacokinetics, pain tolerance to CPT, and Berg balance were impacted comparably between alcohol consumption groups. Women endorsed greater negative drug effects, whereas men endorsed positive drug effects. Independent of subject's age, elevated customary alcohol consumption attenuates opioid central effects (i.e., pupil miosis, impaired cognition) and gender influences subjective drug effects. Clinicians should consider alcohol consumption and gender when prescribing opioid medications. •Oxycodone impact on the central nervous system (CNS) as indicated by pupil constriction (miosis) is reduced or attenuated in middle age persons who consume heavier amounts of alcohol (average 3.3 drinks per day/ 25 drinks per week).•Oxycodone typically impairs cognition around 90 minutes following consumption of a 10mg dose, however, for middle age persons with customary alcohol consumption habits in the heavier range (average 3.3 drinks per day/ 25 drinks per week) there is reduced or minimal impairment of attention, working memory, declarative memory, inhibitory control, and performance on a simulated driving task.•Women in comparison to men, particularly women with elevated levels of customary alcohol consumption, did not demonstrate the typical increase in analgesia from oxycodone (10mg) in response to an experimental pain stimulus.•Male gender, prior experience of drug use and heavier customary alcohol consumption were all associated with stronger endorsement of positive or good drug effects from oxycodone.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Authorship contributions: Monique Cherrier participated in all aspects of the project including study design, primary oversight, regulatory approval and adherence, staff training and management, participant recruitment, data monitoring integrity and analysis, manuscript preparation and submission; Danny Shen participated in study design, ongoing participant enrollment, oversight of biologic specimen accrual, handling storage, integrity and assay process and related staff, data analysis, manuscript preparation and submission; Laura Shireman participated in oversight of biologic specimen accrual, handling, storage, assay process and data integrity, analysis and manuscript preparation; Andrew Saxon participated in study design, medical monitoring and oversight of study procedures and participants, regulatory approval and adherence, data analysis and manuscript preparation; Tracy Simpson participated in manuscript preparation, instrument selection and scoring; Alex Men participated in biologic sample assay process and data integrity; Preetma Kooner participated in medical oversight; Greg Terman participated in medical screening, monitoring and oversight of study participants and procedures, manuscript preparation and institutional support.
ISSN:0091-3057
1873-5177
1873-5177
DOI:10.1016/j.pbb.2021.173295